Nitinol has become a popular material choice for medical devices implanted through minimally invasive procedures due to its highly elastic and shape memory mechanical properties. Element evaluates nickel leaching for medical device manufacturers from nitinol and other nickel-rich medical devices.

Nickel can be immunotoxic for patients, especially those with nickel allergies, and adverse biological responses to released nickel ions are a concern for patient safety. 

While there is no standardized method for the in vitro assessment of nickel leaching, Element has developed a custom test setup that allows for nickel ion quantification during fatigue testing and is at the cutting edge of characterization testing development for the medical device industry.

Guidance for nickel ion release testing 

There are several FDA guidance documents related to intravascular devices with recommendations for nickel ion release. For example, the “Non-Clinical Engineering Tests and Recommended Labeling for Intravascular Stents and Associated Delivery Systems” FDA guidance document contains brief information about nickel ion release testing. The FDA also issued a draft guidance document titled “Technical Considerations for Non-Clinical Assessment of Medical Devices Containing Nitinol,” outlining recommendations for measuring and reporting nickel ion release.

For devices containing nitinol that do not exhibit sufficient corrosion resistance or an adequate passivation layer, FDA guidance documents recommend quantifying nickel ion release over time.

Testing nickel ion release during fatigue – case study

Element’s cardiovascular device testing experts collaborated with the FDA on a study regarding the “Impact of Fatigue Testing and Surface Processing on Nickel Release in Nitinol Stents” (Shap. Mem. Superelasticity, 4: 462-471, 2018). During this study, we utilized our innovative custom test setup to show that dynamic pulsatile fatigue loading accelerated the release of nickel in vitro compared to typical static immersion conditions, emphasizing the importance of assessing nickel release during fatigue testing.

Our nickel ion release test methods

Nickel release testing measures the concentration of nickel leached from the device into a fluid with physiologic temperature and pH. The recommended length of testing for permanent implants is at least 60 days.

Testing for nickel ion release during fatigue testing closely mimics physiologic conditions and captures both the initial bolus release of nickel and the longer-term nickel ion release profile in vitro.  

Nickel ions are captured in a suitable, low volume reservoir as the device is being radially fatigued.  Deployed vessels are filled with a small amount of isolated test media, which absorbs released ions during testing. Isolated media is extracted at several interim time points with most extractions concentrated at the beginning of the test to capture the initial bolus release. Released nickel from the isolated test media is quantified using inductively coupled plasma mass spectrometry (ICP-MS).  

The Element advantage

Element’s test setup can be readily modified for different types of medical devices, for which nickel ion release characterization combined with mechanical loading is desired. For more information about this test, you can also read our article on Nickel Ion Leaching Testing of Nitinol Medical Devices

Contact us for your medical device nickel ion release testing needs. 

Cta_Small_1600x480

Our team of over 6,700 Engaged Experts in North America, Europe, The Middle East, Australia, Asia and Africa are ready to help you.